Statistical Efficiency of Phase II Multiple Sclerosis Clinical Trials with Different MRI Scanning Frequencies

被引：0
|
作者：
Zhao, Y. [1 ]
Chen, J. [1 ]
Li, D. K. B. [1 ]
Riddehough, A. [1 ]
Traboulsee, A. [1 ]
Petkau, A. J. [1 ]
机构：
[1] Univ British Columbia, Vancouver, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [1] Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials
    Liedtke, W
    Limmroth, V
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (02) : 276 - 276
  • [2] MRI as an outcome in multiple sclerosis clinical trials
    Daumer, M.
    Neuhaus, A.
    Morrissey, S.
    Hintzen, R.
    Ebers, G. C.
    [J]. NEUROLOGY, 2009, 72 (08) : 705 - 711
  • [3] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Sormani, Maria Pia
    Pardini, Matteo
    [J]. NEUROTHERAPEUTICS, 2017, 14 (04) : 924 - 933
  • [4] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Maria Pia Sormani
    Matteo Pardini
    [J]. Neurotherapeutics, 2017, 14 : 924 - 933
  • [5] Improving the efficiency of clinical trials in multiple sclerosis
    Marrie, Ruth Ann
    Sormani, Maria Pia
    Mangion, Sean Apap
    Bovis, Francesca
    Cheung, Winson Y.
    Cutter, Gary R.
    Feys, Peter
    Hill, Michael D.
    Koch, Marcus Werner
    McCreary, Morgan
    Mowry, Ellen M.
    Park, Jay J. H.
    Piehl, Fredrik
    Salter, Amber
    Chataway, Jeremy
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (09) : 1136 - 1148
  • [6] MRI AS AN OUTCOME IN MULTIPLE SCLEROSIS CLINICAL TRIALS Reply
    Ebers, George
    Daumer, Martin
    [J]. NEUROLOGY, 2009, 73 (22) : 1932 - 1933
  • [7] Evaluation of an individualized probability index of MRI lesion counts for monitoring patient safety in phase II multiple sclerosis clinical trials
    Zhao, Y.
    Traboulsee, A.
    Li, D. K. B.
    Riddehough, A.
    Tam, R.
    Petkau, A. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 499 - 499
  • [8] Composite MRI score as a biomarker in clinical trials in multiple sclerosis
    Traboulsee, A
    Zhao, YS
    Li, D
    [J]. NEUROLOGY, 2006, 66 (05) : A73 - A74
  • [9] Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results
    Rose, J. W.
    Burns, J. B.
    Bjorklund, J.
    Klein, J.
    Watt, H. E.
    Carlson, G.
    [J]. NEUROLOGY, 2007, 69 (08) : 785 - 789
  • [10] Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
    Rossman, Ian T.
    Cohen, Jeffrey A.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (05) : 489 - 491
12345